Elevation Oncology Stock Shares Owned By Institutions
| ELEVDelisted Stock | USD 0.37 0.00 0.00% |
Fundamental analysis of Elevation Oncology allows traders to better anticipate movements in Elevation Oncology's stock price by examining its financial health and performance throughout various phases of its business cycle.
Elevation |
Elevation Oncology Company Shares Owned By Institutions Analysis
Elevation Oncology's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Elevation Oncology Shares Owned By Institutions | 59.72 % |
Most of Elevation Oncology's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elevation Oncology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
CompetitionBased on the latest financial disclosure, 59% of Elevation Oncology are shares owned by institutions. This is 33.78% higher than that of the Biotechnology sector and 25.73% higher than that of the Health Care industry. The shares owned by institutions for all United States stocks is 52.31% lower than that of the firm.
Elevation Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elevation Oncology's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Elevation Oncology could also be used in its relative valuation, which is a method of valuing Elevation Oncology by comparing valuation metrics of similar companies.Elevation Oncology is currently under evaluation in shares owned by institutions category among its peers.
Elevation Fundamentals
| Return On Equity | -0.78 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | (27.78 M) | |||
| Shares Outstanding | 59.25 M | |||
| Shares Owned By Insiders | 0.35 % | |||
| Shares Owned By Institutions | 59.72 % | |||
| Number Of Shares Shorted | 2.08 M | |||
| Price To Earning | 0.16 X | |||
| Price To Book | 0.46 X | |||
| EBITDA | (44.7 M) | |||
| Net Income | (44.48 M) | |||
| Cash And Equivalents | 122.54 M | |||
| Cash Per Share | 5.26 X | |||
| Total Debt | 31.13 M | |||
| Current Ratio | 6.48 X | |||
| Book Value Per Share | 0.79 X | |||
| Cash Flow From Operations | (36.36 M) | |||
| Short Ratio | 0.91 X | |||
| Earnings Per Share | (0.81) X | |||
| Target Price | 0.4 | |||
| Number Of Employees | 34 | |||
| Beta | 1.5 | |||
| Market Capitalization | 21.63 M | |||
| Total Asset | 95.63 M | |||
| Retained Earnings | (240.46 M) | |||
| Working Capital | 90.26 M | |||
| Net Asset | 95.63 M |
About Elevation Oncology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elevation Oncology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elevation Oncology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elevation Oncology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in commodities. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Elevation Stock
If you are still planning to invest in Elevation Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Elevation Oncology's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |